Skip to main content
Cipla Ltd. logo

Cipla Ltd. — Investor Relations & Filings

Ticker · CIPLA ISIN · INE059A01026 LEI · 335800KMJJYEDDK82Q34 BSE.NS Manufacturing
Open in API
Filings indexed 2,613 across all filing types
Latest filing 2026-05-15 Call Transcript
Country IN India
Listing BSE.NS CIPLA

About Cipla Ltd.

https://www.cipla.com/

Cipla Ltd. is a global pharmaceutical company focused on the development, manufacturing, and marketing of a wide range of generic and branded medicines. The company maintains a diverse portfolio of over 1,500 products across various therapeutic areas, including respiratory, anti-retroviral, urology, cardiology, anti-infective, and central nervous system treatments. It is recognized for its leadership in respiratory care and its historical role in making HIV/AIDS treatment affordable through the introduction of low-cost antiretroviral drugs. Operating with a strong emphasis on research and development, the firm utilizes advanced technology to produce complex generics and drug delivery systems. Its global footprint spans multiple continents, serving healthcare providers and patients in numerous international markets through a robust supply chain and manufacturing infrastructure.

Recent filings

Filing Released Lang Actions
We are enclosing hereby a copy of transcript of the Company''s Q4 FY26 earnings conference call dated 13th May, 2026
Call Transcript Classification · 95% confidence The document is the full transcript of Cipla’s Q4 FY26 earnings conference call, as indicated by the title “Q4 FY26 - Earnings Call Transcript” and the text of a moderated call between management and investors. This clearly matches the definition for Call Transcript (Code: CT).
2026-05-15 English
Copy of Newspaper Publication
Report Publication Announcement Classification · 88% confidence The document is a formal letter from Cipla to stock exchanges under SEBI Listing Regulations 2015 notifying the publication of audited standalone and consolidated financial results for the quarter and year ended March 31, 2026, in newspapers (Business Standard and Sakal). It does not contain the full financial statements or substantive data itself, but simply announces that the results (and auditor’s report) have been approved and published/are available on the company’s and exchange websites. Under the “menu vs meal” rule, it is an announcement of report publication rather than the report itself, fitting the Report Publication Announcement (RPA) category.
2026-05-14 English
Please find attached newspaper advertisement
Report Publication Announcement Classification · 65% confidence The document is a formal letter to stock exchanges enclosing newspaper publications of the audited standalone and consolidated financial results for the quarter and year ended 31 March 2026. It primarily notifies the exchanges of the publication under SEBI Listing Regulations and directs readers to the full results and auditor’s report on the company’s website. It does not present a full annual or interim report itself but announces the publication of the results. Thus, it is best classified as a Report Publication Announcement (RPA).
2026-05-14 English
Allotment of Securities
Share Issue/Capital Change Classification · 87% confidence The document is an official listing compliance announcement under SEBI LODR Regulation 30 notifying stock exchanges of the allotment of 17,915 equity shares on exercise of employee stock options/stock appreciation rights, resulting in an increase in issued share capital. This is a share issue/capital change announcement, matching our "Share Issue/Capital Change" category (SHA).
2026-05-14 English
In compliance with the provisions of regulation 30 of SEBI (Listing Obligation and Disclosure Requirements), Regulations, 2015, we hereby notify that the Operations and Administrative Committee ....
Share Issue/Capital Change Classification · 95% confidence The document is a formal notification under SEBI LODR Regulation 30 of the allottment of 17,915 equity shares under employee stock option and stock appreciation rights schemes, which increases the company’s issued, subscribed and paid‐up share capital. This is an announcement of a share issue and capital change (new shares allotted). Accordingly, it falls under the Share Issue/Capital Change category.
2026-05-14 English
Analysts/Institutional Investor Meet/Con. Call Updates
Regulatory Filings Classification · 65% confidence The document is a brief compliance notification letter to stock exchanges under SEBI LODR regulations, informing about the availability of the audio recording of the earnings conference call on the company website. It does not contain any financial data itself nor is it the earnings release or transcript, but merely an announcement of availability. This fits the ‘Regulatory Filings’ fallback category (RNS).
2026-05-13 English

Browse filings by year

17 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.